Transmissibility of hepatitis B virus (HBV) infection through blood transfusion from blood donors with occult HBV infection

Clinical Infectious Diseases

Volumn 52, Issue 5, 2011, Pages 624-632

  Yuen, Man Fung ^a   Wong, Danny Ka Ho ^a   Lee, Cheuk Kwong ^b   Tanaka, Yasuhito ^c   Allain, Jean Pierre ^e   Fung, James ^a   Leung, Jennifer ^b   Lin, Che Kit ^b   Sugiyama, Masaya ^c   Sugauchi, Fuminaka ^c   Mizokami, Masashi ^d   Lai, Ching Lung ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b HOSPITAL AUTHORITY   (Hong Kong)

^c NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^d NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ADOLESCENT; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CONTROLLED STUDY; FEMALE; GENE SEQUENCE; GENOME; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; LIVER CELL; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OCCULT HEPATITIS B; PHYLOGENY; PRIORITY JOURNAL; RECIPIENT; VIRUS REPLICATION; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; ANIMALS; BLOOD; BLOOD DONORS; BLOOD TRANSFUSION; DISEASE MODELS, ANIMAL; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LIVER; MALE; MICE; MIDDLE AGED; PHYLOGENY; RISK ASSESSMENT; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 79951939032     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciq247     Document Type: Article

References (26)

1. Allain JP, Candotti D. Diagnostic algorithm for HBV safe transfusion. Blood Transfus 2009;7:174-82.
2. Liu CJ, Lo SC, Kao JH, et al. Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan. J Hepatol 2006;44:39-46.
3. Song EY, Yun YM, Park MH, Seo DH. Prevalence of occult hepatitis B virus infection in a general adult population in Korea. Intervirology 2009;52:57-62.
4. Bhatti FA, Ullah Z, Salamat N, Ayub M, Ghani E. Anti-hepatitis B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice. Transfusion 2007;47:74-9. (Pubitemid 46006312)
5. Yuen MF, Wong DK, Fung J, et al. HBsAg seroclearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma. Gastroenterology 2008;135:1192-9.
6. Werle-Lapostolle B, Bowden S, Locarnini S, et al. Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. Gastroenterology 2004;126:1750-8. (Pubitemid 38736340)
7. Allain JP, Candotti D, Soldan K, et al. The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana. Blood 2003;101:2419-25. (Pubitemid 36302091)
8. Tateno C, Yoshizane Y, Saito N, et al. Near completely humanized liver in mice shows human-type metabolic responses to drugs. Am J Pathol 2004;165:901-12. (Pubitemid 39129297)
9. Abe A, Inoue K, Tanaka T, et al. Quantitation of hepatitis B virus genomic DNA by real-time detection PCR. J Clin Microbiol 1999;37:2899-03.
10. Mason AL, Xu L, Guo L, Kuhns M, Perrillo RP. Molecular basis for persistent hepatitis B virus infection in the liver after clearance of serum hepatitis B surface antigen. Hepatology 1998;27:1736-42. (Pubitemid 28264703)
11. Lin HJ, Lai CL, Lau JY, Chung HT, Lauder IJ, Fong MW. Evidence for intrafamilial transmission of hepatitis B virus from sequence analysis of mutant HBV DNAs in two Chinese families. Lancet 1990;336:208-12. (Pubitemid 20229060)
12. Thompson JD, Gibson TJ, Plewniak F, et al. The CLUSTAL-X windows interface: flexible strategies for multiple sequence alignment added by quality analysis tools. Nucleic Acids Res 1997;25:4876-82. (Pubitemid 28022245)
13. Tamura K, Dudley J, Nei M, Kumar S. MEGA4 Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007;24:1596-9. (Pubitemid 47236692)
14. Lin CL, Kao JH, Chen BF, Chen PJ, Lai MY, Chen DS. Application of hepatitis B virus genotyping and phylogenetic analysis in intrafamilial transmission of hepatitis B virus. Clin Infect Dis 2005;41:1576-81.
15. Tajiri H, Tanaka Y, Kagimoto S, Murakami J, Tokuhara D, Mizokami M. Molecular evidence of father-to-child transmission of hepatitis B virus. J Med Virol 2007;79:922-26. (Pubitemid 46871548)
16. Hoofnagle JH, Seeff LB, Bales ZB, Barker LF. Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. N Engl J Med 1978;298:1379-83. (Pubitemid 8358627)
17. Lander JJ, Gitnick GL, Gelb LH, Aach RD. Anticore antibody screening of transfused blood. ox Sang 1978;34:77-80. (Pubitemid 8222079)
18. Koziol DE, Holland PV, Alling DW. Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. Ann Intern Med 1986;104:488-95. (Pubitemid 16137808)
19. Sugg U, Schenzle D, Hess G. Antibodies to hepatitis B core antigen in blood donors screened for alanine aminotransferase level and hepatitis non-A, non-B in recipients. Transfusion 1988;28:386-8.
20. Allain JP. Occult hepatitis B virus infection: implications in transfusion. ox Sang 2004;86:83-91.
21. Wands JR, Chura CM, Roll FJ, Maddrey WC. Serial studies of hepatitisassociated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders. Gastroenterology 1975;68:105-12.
22. Velati C, RomanòL, Fomiatti L, Baruffi L, Zanetti AR; SIMTI Research Group. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey. Transfusion 2008;48:2205-13.
23. Mosley JW, Stevens CE, Aach RD, et al. Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients. Transfusion 1995;35:5-12.
24. Satake M, Taira R, Yugi H, et al. Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program. Transfusion 2007;47:1197-205. (Pubitemid 46934327)
25. Levicnik-Stezinar S, Rahne-Potokar U, Candotti D, Lelie N, Allain JP. Anti-HBs positive occult hepatitis B virus carrier blood infectious in two transfusion recipients. J Hepatol 2008;48:1022-5.
26. Yuen MF, Lee CK, Wong DK, et al. Prevalence of occult hepatitis B infection in a highly endemic area for chronic hepatitis B: a study of a large blood donor population. Gut 2010;59:1389-93.